Geron (GERN) Exchange Rate Effect (2022 - 2026)
Geron's (GERN) quarterly Exchange Rate Effect came in at -$36000.0 in Q1 2026, down 300.0% year-on-year from $18000.0 in Q1 2025, and down 300.0% quarter-over-quarter from -$9000.0 in Q4 2025.
Geron (GERN) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Geron has disclosed Exchange Rate Effect across 4 years of filings, most recently posting -$36000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$36000.0, down 300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $33000.0 (up 106.25% YoY), and the FY2025 annual result was $87000.0, up 825.0% from the prior year.
- Exchange Rate Effect came in at -$36000.0 for Q1 2026 at Geron, down from -$9000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $75000.0 in Q3 2025 to a low of -$36000.0 in Q1 2026.
- The 4-year median for Exchange Rate Effect is -$4000.0 (2022), against an average of $4000.0.
- Across the five-year window, Exchange Rate Effect surged 280.0% in 2025 and plunged 300.0% in 2026, its largest moves.
- Geron's Exchange Rate Effect stood at $1000.0 in 2022, then sank by 3000.0% to -$29000.0 in 2024, then soared by 68.97% to -$9000.0 in 2025, then slumped by 300.0% to -$36000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$36000.0 (Q1 2026), -$9000.0 (Q4 2025), and $75000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | -36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -29,000.00 |
| Dec 31, 2024 | -29,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -21,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |